PARNELL PHARMACEUT HLDGS LTD - SHS (PARNF)

CUSIP: Q73622104

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / SHS
Total 13F shares
3,018,374
Share change
-555,843
Total reported value
$14,940,000
Price per share
$4.95
Number of holders
12
Value change
-$2,732,965
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP Q73622104?
CUSIP Q73622104 identifies PARNF - PARNELL PHARMACEUT HLDGS LTD - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PARNELL PHARMACEUT HLDGS LTD - SHS (PARNF) as of Q2 2015

As of 30 Jun 2015, PARNELL PHARMACEUT HLDGS LTD - SHS (PARNF) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,018,374 shares. The largest 10 holders included FMR LLC, BlackRock Advisors LLC, Artal Group S.A., Endurant Capital Management LP, BlackRock Group LTD, Alyeska Investment Group, L.P., JPMORGAN CHASE & CO, BlackRock Investment Management, LLC, PERCEPTIVE ADVISORS LLC, and GOLDMAN SACHS GROUP INC. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.